Combining semaglutide (a GLP-1 receptor agonist) with phentermine (a sympathomimetic) is not FDA-approved as a formal combination, but some providers explore this approach off-label based on differing mechanisms of action
Can women use these peptides
Semaglutide, for example, is a powerful medication that offers hope for effective, lasting weight loss
It emphasizes that your complete medical history, prior GI issues, and medication sensitivities should inform which route a prescriber ultimately chooses
The severe side effects, particularly gastroparesis, can result in chronic nausea, malnutrition, and other long-term health challenges